Literature DB >> 12115886

Tenascin-C is a useful marker for disease activity in myocarditis.

Kyoko Imanaka-Yoshida1, Michiaki Hiroe, Yasuhiro Yasutomi, Tetsuya Toyozaki, Takuro Tsuchiya, Naomi Noda, Toshiki Maki, Toshio Nishikawa, Teruyo Sakakura, Toshimichi Yoshida.   

Abstract

Tenascin-C (TNC) is an extracellular matrix protein which appears at active sites of tissue remodelling during embryogenesis or cancer invasion. In normal heart, TNC is only present during the early stages of development but reappears in pathological states. This study examined the diagnostic value of TNC for assessing disease activity of myocarditis. Expression of TNC was examined in myosin-induced autoimmune myocarditis mouse models. Sequential changes in amount, localization and the producing cells were analysed by reverse transcriptase-polymerase chain reaction, western blotting, immunohistochemistry and in situ hybridization and compared with the histological picture. The expression of TNC was upregulated at a very early stage of myocarditis. Immunostaining was detectable before cell infiltration and myocytolysis became histologically apparent, remained during the active stage while cell infiltration and necrosis continued, and disappeared in scar tissue with healing. TNC immunostaining was always observed at the periphery of necrotic or degenerating cardiomyocytes in foci of inflammation, the expression level correlating with histological evidence of inflammatory activity. Interstitial fibroblasts were the major source of TNC, expressing the large isoform containing alternative splicing sites. These data demonstrate that TNC is a useful marker for evaluation of disease activity in myocarditis. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115886     DOI: 10.1002/path.1131

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  43 in total

Review 1.  Imaging inflammatory cardiomyopathies.

Authors:  Dominique Le Guludec; Laure Sarda; Francois Rouzet; Pascal Merlet; Michel S Slama; Rachida Lebtahi
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  High tenascin-C levels cause inadequate myocardial blush grade in patients with acute myocardial infarction.

Authors:  Ozlem Arican Ozluk; Dursun Topal; Erhan Tenekecioglu; Tezcan Peker; Mustafa Yilmaz; Kemal Karaagac; Fahriye Vatansever; Bedrettin Boyraz; Omur Aydın
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall.

Authors:  Karola Trescher; Barbara Thometich; Svitlana Demyanets; Hermann Kassal; Roland Sedivy; Reginald Bittner; Christoph Holzinger; Bruno K Podesser
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-08

Review 5.  Histochemistry and cell biology: the annual review 2010.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2011-01-29       Impact factor: 4.304

Review 6.  A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens.

Authors:  Hannah Tomlin; Anna M Piccinini
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

Review 7.  Tenascin-C in cardiovascular remodeling: potential impact for diagnosis, prognosis estimation and targeted therapy.

Authors:  Marcus Franz; Christian Jung; Alexander Lauten; Hans R Figulla; Alexander Berndt
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

8.  Serum tenascin-C level is associated with coronary plaque rupture in patients with acute coronary syndrome.

Authors:  Nobuo Sakamoto; Yasuto Hoshino; Tomofumi Misaka; Hiroyuki Mizukami; Satoshi Suzuki; Koichi Sugimoto; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  Heart Vessels       Date:  2013-03-27       Impact factor: 2.037

9.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16

Review 10.  Molecular signatures and the study of gene expression profiles in inflammatory heart diseases.

Authors:  V Ruppert; B Maisch
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.